1 Data
\(\text{Table}\:\text{1.}\) Robot vs
LPS+LESS
|
|
Robot
|
LPS+LESS
|
|
|
NxUx
|
454
|
1532
|
1986
|
|
Segmental
|
25
|
13
|
38
|
|
|
479
|
1545
|
2024
|
1.1 Baseline
Patient’s Baseline Characteristics
|
|
level
|
1 ROBOT
|
2 LPS+LESS
|
p
|
test
|
SMD
|
|
n
|
|
479
|
1545
|
|
|
|
|
NUx (%)
|
1 ROBOT
|
454 (94.8)
|
0 ( 0.0)
|
<0.001
|
|
16.493
|
|
|
2 LPS+LESS
|
0 ( 0.0)
|
1532 (99.2)
|
|
|
|
|
|
NA
|
25 ( 5.2)
|
13 ( 0.8)
|
|
|
|
|
Segmental (%)
|
1 ROBOT
|
25 ( 5.2)
|
0 ( 0.0)
|
<0.001
|
|
0.357
|
|
|
2 LPS+LESS
|
0 ( 0.0)
|
13 ( 0.8)
|
|
|
|
|
|
NA
|
454 (94.8)
|
1532 (99.2)
|
|
|
|
|
ECOG (%)
|
0 無症狀
|
248 (51.8)
|
609 (39.4)
|
<0.001
|
|
0.521
|
|
|
1 有症狀,可步行對生活不影響
|
187 (39.0)
|
536 (34.7)
|
|
|
|
|
|
2 躺在床上時間小於50%
|
22 ( 4.6)
|
83 ( 5.4)
|
|
|
|
|
|
3 躺在床上時間大於50%
|
3 ( 0.6)
|
9 ( 0.6)
|
|
|
|
|
|
4 完全臥床
|
0 ( 0.0)
|
4 ( 0.3)
|
|
|
|
|
|
NA
|
19 ( 4.0)
|
304 (19.7)
|
|
|
|
|
性別 (%)
|
1 男
|
202 (42.2)
|
636 (41.2)
|
0.736
|
|
0.020
|
|
|
2 女
|
277 (57.8)
|
909 (58.8)
|
|
|
|
|
BMI (%)
|
1 Normal
|
228 (47.6)
|
582 (37.7)
|
<0.001
|
|
0.321
|
|
|
2 Overweight
|
133 (27.8)
|
354 (22.9)
|
|
|
|
|
|
NA
|
118 (24.6)
|
609 (39.4)
|
|
|
|
|
Cell_Type (%)
|
1 urothelial
|
414 (86.4)
|
1390 (90.0)
|
0.090
|
|
0.111
|
|
|
5 UC with variants (Squamous cell, glandular, sarcomatous, micro
papillary, neuroendocrine, lymphoepithelial)
|
61 (12.7)
|
147 ( 9.5)
|
|
|
|
|
|
6 others
|
4 ( 0.8)
|
8 ( 0.5)
|
|
|
|
|
左右側 (%)
|
1 左
|
249 (52.0)
|
802 (51.9)
|
0.990
|
|
0.008
|
|
|
2 右
|
223 (46.6)
|
719 (46.5)
|
|
|
|
|
|
3 雙側
|
7 ( 1.5)
|
24 ( 1.6)
|
|
|
|
|
腫瘤位置 (%)
|
0 non-visible
|
1 ( 0.2)
|
1 ( 0.1)
|
0.517
|
|
0.104
|
|
|
1 腎盂
|
186 (38.8)
|
655 (42.4)
|
|
|
|
|
|
2 輸尿管
|
175 (36.5)
|
500 (32.4)
|
|
|
|
|
|
3 膀胱袖口
|
1 ( 0.2)
|
2 ( 0.1)
|
|
|
|
|
|
4 多個位置
|
115 (24.0)
|
385 (24.9)
|
|
|
|
|
|
5 無法識別
|
1 ( 0.2)
|
2 ( 0.1)
|
|
|
|
|
多發性 (%)
|
0 Not available
|
19 ( 4.0)
|
92 ( 6.0)
|
0.246
|
|
0.092
|
|
|
1 No
|
295 (61.6)
|
936 (60.6)
|
|
|
|
|
|
2 Yes
|
165 (34.4)
|
517 (33.5)
|
|
|
|
|
腫瘤大小 (%)
|
0 Not available
|
7 ( 1.5)
|
56 ( 3.6)
|
0.050
|
|
0.141
|
|
|
1 <2cm
|
153 (31.9)
|
462 (29.9)
|
|
|
|
|
|
2 >=2cm
|
319 (66.6)
|
1027 (66.5)
|
|
|
|
|
病理分期 (%)
|
1 stage 0a/0is
|
73 (15.2)
|
241 (15.6)
|
0.018
|
|
0.185
|
|
|
2 stage I
|
118 (24.6)
|
436 (28.2)
|
|
|
|
|
|
3 stage II
|
79 (16.5)
|
296 (19.2)
|
|
|
|
|
|
4 stage III
|
144 (30.1)
|
442 (28.6)
|
|
|
|
|
|
5 stage IV
|
52 (10.9)
|
106 ( 6.9)
|
|
|
|
|
|
NA
|
13 ( 2.7)
|
24 ( 1.6)
|
|
|
|
|
完整檢體腫瘤惡性度 (%)
|
1 papillary urothelial neoplasm of low malignant potential
|
1 ( 0.2)
|
1 ( 0.1)
|
0.185
|
|
0.124
|
|
|
2 low grade
|
47 ( 9.8)
|
140 ( 9.1)
|
|
|
|
|
|
3 high grade
|
418 (87.3)
|
1372 (88.8)
|
|
|
|
|
|
4 Gx
|
2 ( 0.4)
|
15 ( 1.0)
|
|
|
|
|
|
NA
|
11 ( 2.3)
|
17 ( 1.1)
|
|
|
|
|
合併膀胱腫瘤 (%)
|
0 No
|
356 (74.3)
|
1078 (69.8)
|
0.096
|
|
0.159
|
|
|
1 Previous Hx of bladder UC
|
33 ( 6.9)
|
114 ( 7.4)
|
|
|
|
|
|
2 Concurrent Bladder UC
|
70 (14.6)
|
261 (16.9)
|
|
|
|
|
|
3 Not available
|
14 ( 2.9)
|
41 ( 2.7)
|
|
|
|
|
|
NA
|
6 ( 1.3)
|
51 ( 3.3)
|
|
|
|
|
合併CIS (%)
|
0 No
|
323 (67.4)
|
1060 (68.6)
|
0.062
|
|
0.133
|
|
|
1 Yes
|
149 (31.1)
|
434 (28.1)
|
|
|
|
|
|
NA
|
7 ( 1.5)
|
51 ( 3.3)
|
|
|
|
|
Lymphovascular_invasion (%)
|
0 No
|
366 (76.4)
|
1256 (81.3)
|
<0.001
|
|
0.189
|
|
|
1 Yes
|
92 (19.2)
|
267 (17.3)
|
|
|
|
|
|
NA
|
21 ( 4.4)
|
22 ( 1.4)
|
|
|
|
|
surgical_margin (%)
|
0 free
|
449 (93.7)
|
1472 (95.3)
|
0.066
|
|
0.117
|
|
|
1 positive
|
26 ( 5.4)
|
51 ( 3.3)
|
|
|
|
|
|
NA
|
4 ( 0.8)
|
22 ( 1.4)
|
|
|
|
|
術前水腎 (%)
|
1 No
|
207 (43.2)
|
719 (46.5)
|
0.137
|
|
0.106
|
|
|
2 Yes
|
258 (53.9)
|
761 (49.3)
|
|
|
|
|
|
NA
|
14 ( 2.9)
|
65 ( 4.2)
|
|
|
|
|
Tumor_Necrosis (%)
|
0 No
|
412 (86.0)
|
1133 (73.3)
|
<0.001
|
|
0.439
|
|
|
1 Yes
|
57 (11.9)
|
208 (13.5)
|
|
|
|
|
|
NA
|
10 ( 2.1)
|
204 (13.2)
|
|
|
|
|
有無針對UTUC化療 (%)
|
0 No
|
321 (67.0)
|
1075 (69.6)
|
0.018
|
|
0.155
|
|
|
1 Yes
|
148 (30.9)
|
404 (26.1)
|
|
|
|
|
|
2 Not available
|
10 ( 2.1)
|
66 ( 4.3)
|
|
|
|
|
針對UTUC化療型態 (%)
|
0 No & Unknown
|
331 (69.1)
|
1139 (73.7)
|
0.008
|
|
0.176
|
|
|
1 neo-adjuvant
|
20 ( 4.2)
|
42 ( 2.7)
|
|
|
|
|
|
2 adjuvant
|
92 (19.2)
|
297 (19.2)
|
|
|
|
|
|
3 salvage (curative intent)
|
13 ( 2.7)
|
15 ( 1.0)
|
|
|
|
|
|
4 palliative (S/S relieve)
|
23 ( 4.8)
|
52 ( 3.4)
|
|
|
|
|
化療處方 (%)
|
0 No & Unknown
|
336 (70.1)
|
1150 (74.4)
|
0.079
|
|
0.151
|
|
|
1 Gemcitabine & cisplatin
|
39 ( 8.1)
|
125 ( 8.1)
|
|
|
|
|
|
2 MVAC
|
10 ( 2.1)
|
11 ( 0.7)
|
|
|
|
|
|
3 Taxans-based
|
0 ( 0.0)
|
1 ( 0.1)
|
|
|
|
|
|
4 Carboplatin-based
|
49 (10.2)
|
141 ( 9.1)
|
|
|
|
|
|
5 others
|
45 ( 9.4)
|
117 ( 7.6)
|
|
|
|
|
Bladder_cuff_resection (%)
|
0 Not perform BCR
|
11 ( 2.3)
|
47 ( 3.0)
|
<0.001
|
|
2.194
|
|
|
1 Open incision
|
92 (19.2)
|
1027 (66.5)
|
|
|
|
|
|
2 Transurethral incision
|
9 ( 1.9)
|
55 ( 3.6)
|
|
|
|
|
|
4 Laparoscopy
|
6 ( 1.3)
|
306 (19.8)
|
|
|
|
|
|
5 Robot assisted
|
321 (67.0)
|
5 ( 0.3)
|
|
|
|
|
|
NA
|
40 ( 8.4)
|
105 ( 6.8)
|
|
|
|
|
simultaneously_ipsilateral_adrenalectomy (%)
|
0 No
|
408 (85.2)
|
1205 (78.0)
|
0.001
|
|
0.202
|
|
|
1 Yes
|
26 ( 5.4)
|
95 ( 6.1)
|
|
|
|
|
|
NA
|
45 ( 9.4)
|
245 (15.9)
|
|
|
|
|
Post_operation_intravesical_CT_instillation (%)
|
1 No
|
356 (74.3)
|
1370 (88.7)
|
<0.001
|
|
0.477
|
|
|
2 術中膀胱灌藥
|
41 ( 8.6)
|
6 ( 0.4)
|
|
|
|
|
|
3 術後膀胱灌藥
|
38 ( 7.9)
|
51 ( 3.3)
|
|
|
|
|
|
NA
|
44 ( 9.2)
|
118 ( 7.6)
|
|
|
|
|
Clavien_Dindo_classification (%)
|
0 No Complication
|
284 (59.3)
|
905 (58.6)
|
0.011
|
|
0.243
|
|
|
1 Grade I
|
78 (16.3)
|
175 (11.3)
|
|
|
|
|
|
2 Grade II
|
76 (15.9)
|
239 (15.5)
|
|
|
|
|
|
3 Grade IIIa
|
4 ( 0.8)
|
14 ( 0.9)
|
|
|
|
|
|
4 Grade IIIb
|
4 ( 0.8)
|
21 ( 1.4)
|
|
|
|
|
|
5 Grade IVa
|
3 ( 0.6)
|
16 ( 1.0)
|
|
|
|
|
|
6 Grade IVb
|
0 ( 0.0)
|
1 ( 0.1)
|
|
|
|
|
|
7 Grade V
|
3 ( 0.6)
|
6 ( 0.4)
|
|
|
|
|
|
NA
|
27 ( 5.6)
|
168 (10.9)
|
|
|
|
|
Disease_free (%)
|
0 No
|
361 (75.4)
|
1281 (82.9)
|
<0.001
|
|
0.187
|
|
|
1 Yes
|
118 (24.6)
|
264 (17.1)
|
|
|
|
|
Mortality (%)
|
0 No
|
340 (71.0)
|
924 (59.8)
|
<0.001
|
|
0.237
|
|
|
1 Yes
|
139 (29.0)
|
621 (40.2)
|
|
|
|
|
術後住院天數_day (mean (SD))
|
|
7.60 (4.16)
|
8.44 (5.67)
|
0.004
|
|
0.168
|
|
手術到死亡間隔時間_月 (mean (SD))
|
|
24.10 (17.50)
|
38.73 (32.69)
|
<0.001
|
|
0.558
|
|
診斷年紀 (mean (SD))
|
|
69.29 (10.23)
|
68.74 (10.49)
|
0.309
|
|
0.054
|
|
Followup (mean (SD))
|
|
48.01 (95.82)
|
52.86 (40.04)
|
0.115
|
|
0.066
|
|
Followup_DF (mean (SD))
|
|
31.35 (22.81)
|
39.23 (31.63)
|
<0.001
|
|
0.286
|
2 Imputation
We utilize MICE to impute the missing value, since too
much missing value.
2.1 MICE
MICE stands for Multivariate Imputation by Chained Equations. It is a
statistical method used to handle missing data in a dataset. The process
uses multiple imputation techniques to fill in the missing data and then
combines the results from multiple imputations to produce a final
imputed dataset.
\(\text{Table}\:\text{2.}\) Robot vs
LPS+LESS after imputing and cleaning
|
|
Robot
|
LPS+LESS
|
|
|
NxUx
|
424
|
1147
|
1571
|
|
Segmental
|
24
|
10
|
34
|
|
|
448
|
1157
|
1605
|
Patient’s Baseline after MICE
|
|
level
|
1 Robot
|
2 LPS+LESS
|
p
|
test
|
SMD
|
|
n
|
|
448
|
1157
|
|
|
|
|
NUx (%)
|
1 ROBOT
|
424 (100.0)
|
0 ( 0.0)
|
<0.001
|
|
NaN
|
|
|
2 LPS+LESS
|
0 ( 0.0)
|
1147 (100.0)
|
|
|
|
|
Segmental (%)
|
1 ROBOT
|
24 (100.0)
|
0 ( 0.0)
|
<0.001
|
|
NaN
|
|
|
2 LPS+LESS
|
0 ( 0.0)
|
10 (100.0)
|
|
|
|
|
ECOG (%)
|
0 無症狀
|
248 ( 55.4)
|
564 ( 48.7)
|
0.077
|
|
0.173
|
|
|
1 有症狀,可步行對生活不影響
|
176 ( 39.3)
|
501 ( 43.3)
|
|
|
|
|
|
2 躺在床上時間小於50%
|
21 ( 4.7)
|
77 ( 6.7)
|
|
|
|
|
|
3 躺在床上時間大於50%
|
3 ( 0.7)
|
9 ( 0.8)
|
|
|
|
|
|
4 完全臥床
|
0 ( 0.0)
|
6 ( 0.5)
|
|
|
|
|
性別 (%)
|
1 男
|
188 ( 42.0)
|
473 ( 40.9)
|
0.735
|
|
0.022
|
|
|
2 女
|
260 ( 58.0)
|
684 ( 59.1)
|
|
|
|
|
BMI (%)
|
1 Normal
|
287 ( 64.1)
|
709 ( 61.3)
|
0.330
|
|
0.058
|
|
|
2 Overweight
|
161 ( 35.9)
|
448 ( 38.7)
|
|
|
|
|
Cell_Type (%)
|
1 urothelial
|
386 ( 86.2)
|
1017 ( 87.9)
|
0.412
|
|
0.070
|
|
|
5 UC with variants
|
58 ( 12.9)
|
135 ( 11.7)
|
|
|
|
|
|
6 others
|
4 ( 0.9)
|
5 ( 0.4)
|
|
|
|
|
左右側 (%)
|
1 左
|
227 ( 50.7)
|
608 ( 52.5)
|
0.795
|
|
0.038
|
|
|
2 右
|
214 ( 47.8)
|
532 ( 46.0)
|
|
|
|
|
|
3 雙側
|
7 ( 1.6)
|
17 ( 1.5)
|
|
|
|
|
腫瘤位置 (%)
|
0 non-visible
|
1 ( 0.2)
|
1 ( 0.1)
|
0.760
|
|
0.074
|
|
|
1 腎盂
|
174 ( 38.8)
|
484 ( 41.8)
|
|
|
|
|
|
2 輸尿管
|
163 ( 36.4)
|
391 ( 33.8)
|
|
|
|
|
|
3 膀胱袖口
|
1 ( 0.2)
|
2 ( 0.2)
|
|
|
|
|
|
4 多個位置
|
109 ( 24.3)
|
279 ( 24.1)
|
|
|
|
|
多發性 (%)
|
0 Not available
|
10 ( 2.2)
|
20 ( 1.7)
|
0.560
|
|
0.059
|
|
|
1 No
|
279 ( 62.3)
|
750 ( 64.8)
|
|
|
|
|
|
2 Yes
|
159 ( 35.5)
|
387 ( 33.4)
|
|
|
|
|
腫瘤大小 (%)
|
0 Not available
|
5 ( 1.1)
|
10 ( 0.9)
|
0.197
|
|
0.099
|
|
|
1 <2cm
|
144 ( 32.1)
|
322 ( 27.8)
|
|
|
|
|
|
2 >=2cm
|
299 ( 66.7)
|
825 ( 71.3)
|
|
|
|
|
病理分期 (%)
|
1 stage 0a/0is
|
76 ( 17.0)
|
205 ( 17.7)
|
0.243
|
|
0.126
|
|
|
2 stage I
|
115 ( 25.7)
|
296 ( 25.6)
|
|
|
|
|
|
3 stage II
|
74 ( 16.5)
|
218 ( 18.8)
|
|
|
|
|
|
4 stage III
|
136 ( 30.4)
|
355 ( 30.7)
|
|
|
|
|
|
5 stage IV
|
47 ( 10.5)
|
83 ( 7.2)
|
|
|
|
|
完整檢體腫瘤惡性度 (%)
|
1 papillary urothelial neoplasm of low malignant potential
|
1 ( 0.2)
|
0 ( 0.0)
|
0.394
|
|
0.075
|
|
|
2 low grade
|
48 ( 10.7)
|
126 ( 10.9)
|
|
|
|
|
|
3 high grade
|
395 ( 88.2)
|
1024 ( 88.5)
|
|
|
|
|
|
4 Gx
|
4 ( 0.9)
|
7 ( 0.6)
|
|
|
|
|
合併膀胱腫瘤 (%)
|
0 No
|
341 ( 76.1)
|
857 ( 74.1)
|
0.745
|
|
0.063
|
|
|
1 Previous Hx of bladder UC
|
30 ( 6.7)
|
95 ( 8.2)
|
|
|
|
|
|
2 Concurrent Bladder UC
|
68 ( 15.2)
|
179 ( 15.5)
|
|
|
|
|
|
3 Not available
|
9 ( 2.0)
|
26 ( 2.2)
|
|
|
|
|
合併CIS (%)
|
0 No
|
311 ( 69.4)
|
822 ( 71.0)
|
0.562
|
|
0.036
|
|
|
1 Yes
|
137 ( 30.6)
|
335 ( 29.0)
|
|
|
|
|
Lymphovascular_invasion (%)
|
0 No
|
359 ( 80.1)
|
946 ( 81.8)
|
0.497
|
|
0.041
|
|
|
1 Yes
|
89 ( 19.9)
|
211 ( 18.2)
|
|
|
|
|
surgical_margin (%)
|
0 Free
|
423 ( 94.4)
|
1121 ( 96.9)
|
0.030
|
|
0.121
|
|
|
1 Positive
|
25 ( 5.6)
|
36 ( 3.1)
|
|
|
|
|
術前水腎 (%)
|
0 No
|
197 ( 44.0)
|
512 ( 44.3)
|
0.964
|
|
0.006
|
|
|
1 Yes
|
251 ( 56.0)
|
645 ( 55.7)
|
|
|
|
|
Tumor_Necrosis (%)
|
0 No
|
391 ( 87.3)
|
983 ( 85.0)
|
0.269
|
|
0.067
|
|
|
1 Yes
|
57 ( 12.7)
|
174 ( 15.0)
|
|
|
|
|
有無針對UTUC化療 (%)
|
0 No
|
309 ( 69.0)
|
824 ( 71.2)
|
0.675
|
|
0.049
|
|
|
1 Yes
|
133 ( 29.7)
|
319 ( 27.6)
|
|
|
|
|
|
2 Not available
|
6 ( 1.3)
|
14 ( 1.2)
|
|
|
|
|
針對UTUC化療型態 (%)
|
0 No & Unknown
|
315 ( 70.3)
|
836 ( 72.3)
|
0.167
|
|
0.132
|
|
|
1 neo-adjuvant
|
18 ( 4.0)
|
37 ( 3.2)
|
|
|
|
|
|
2 adjuvant
|
84 ( 18.8)
|
233 ( 20.1)
|
|
|
|
|
|
3 salvage (curative intent)
|
10 ( 2.2)
|
11 ( 1.0)
|
|
|
|
|
|
4 palliative (S/S relieve)
|
21 ( 4.7)
|
40 ( 3.5)
|
|
|
|
|
化療處方 (%)
|
0 No & Unknown
|
319 ( 71.2)
|
842 ( 72.8)
|
NaN
|
|
0.144
|
|
|
1 Gemcitabine & cisplatin
|
32 ( 7.1)
|
109 ( 9.4)
|
|
|
|
|
|
2 MVAC
|
10 ( 2.2)
|
11 ( 1.0)
|
|
|
|
|
|
3 Taxans-based
|
0 ( 0.0)
|
0 ( 0.0)
|
|
|
|
|
|
5 others
|
87 ( 19.4)
|
195 ( 16.9)
|
|
|
|
|
Bladder_cuff_resection (%)
|
0 Not perform BCR
|
12 ( 2.7)
|
47 ( 4.1)
|
<0.001
|
|
2.409
|
|
|
1 Open incision
|
91 ( 20.3)
|
763 ( 65.9)
|
|
|
|
|
|
2 Transurethral incision
|
11 ( 2.5)
|
57 ( 4.9)
|
|
|
|
|
|
4 Laparoscopy
|
6 ( 1.3)
|
286 ( 24.7)
|
|
|
|
|
|
5 Robot assisted
|
328 ( 73.2)
|
4 ( 0.3)
|
|
|
|
|
simultaneously_ipsilateral_adrenalectomy (%)
|
0 No
|
422 ( 94.2)
|
1073 ( 92.7)
|
0.355
|
|
0.059
|
|
|
1 Yes
|
26 ( 5.8)
|
84 ( 7.3)
|
|
|
|
|
Post_operation_intravesical_CT_instillation (%)
|
0 No
|
372 ( 83.0)
|
1102 ( 95.2)
|
<0.001
|
|
0.439
|
|
|
1 術中膀胱灌藥
|
37 ( 8.3)
|
6 ( 0.5)
|
|
|
|
|
|
2 術後膀胱灌藥
|
39 ( 8.7)
|
49 ( 4.2)
|
|
|
|
|
Clavien_Dindo_classification (%)
|
0 No Complication
|
284 ( 63.4)
|
741 ( 64.0)
|
0.677
|
|
0.130
|
|
|
1 Grade I
|
78 ( 17.4)
|
174 ( 15.0)
|
|
|
|
|
|
2 Grade II
|
72 ( 16.1)
|
187 ( 16.2)
|
|
|
|
|
|
3 Grade IIIa
|
4 ( 0.9)
|
11 ( 1.0)
|
|
|
|
|
|
4 Grade IIIb
|
4 ( 0.9)
|
21 ( 1.8)
|
|
|
|
|
|
5 Grade IVa
|
3 ( 0.7)
|
16 ( 1.4)
|
|
|
|
|
|
6 Grade IVb
|
0 ( 0.0)
|
1 ( 0.1)
|
|
|
|
|
|
7 Grade V
|
3 ( 0.7)
|
6 ( 0.5)
|
|
|
|
|
Disease_free (%)
|
0 No
|
341 ( 76.1)
|
938 ( 81.1)
|
0.032
|
|
0.121
|
|
|
1 Yes
|
107 ( 23.9)
|
219 ( 18.9)
|
|
|
|
|
Mortality (%)
|
0 No
|
321 ( 71.7)
|
778 ( 67.2)
|
0.100
|
|
0.096
|
|
|
1 Yes
|
127 ( 28.3)
|
379 ( 32.8)
|
|
|
|
|
術後住院天數_day (mean (SD))
|
|
7.60 (4.16)
|
8.47 (5.74)
|
0.004
|
|
0.172
|
|
診斷年紀 (mean (SD))
|
|
69.38 (10.16)
|
69.25 (10.11)
|
0.824
|
|
0.012
|
|
Followup (mean (SD))
|
|
43.89 (30.48)
|
51.35 (39.23)
|
<0.001
|
|
0.212
|
|
Followup_DF (mean (SD))
|
|
31.41 (22.57)
|
37.20 (30.14)
|
<0.001
|
|
0.218
|
3 Overlap Weighting

After
after overlap weighting
|
|
level
|
1 Robot
|
2 LPS+LESS
|
p
|
test
|
SMD
|
|
n
|
|
448.0
|
1157.0
|
|
|
|
|
Clavien_Dindo_classification (%)
|
0 No Complication
|
254.1 (56.7)
|
740.0 (64.0)
|
0.339
|
|
0.229
|
|
|
1 Grade I
|
79.3 (17.7)
|
164.3 (14.2)
|
|
|
|
|
|
2 Grade II
|
101.1 (22.6)
|
212.1 (18.3)
|
|
|
|
|
|
3 Grade IIIa
|
8.9 ( 2.0)
|
11.7 ( 1.0)
|
|
|
|
|
|
4 Grade IIIb
|
4.2 ( 0.9)
|
15.8 ( 1.4)
|
|
|
|
|
|
5 Grade IVa
|
0.1 ( 0.0)
|
8.5 ( 0.7)
|
|
|
|
|
|
6 Grade IVb
|
0.0 ( 0.0)
|
1.0 ( 0.1)
|
|
|
|
|
|
7 Grade V
|
0.2 ( 0.0)
|
3.6 ( 0.3)
|
|
|
|
|
術後住院天數_day (mean (SD))
|
|
7.36 (3.39)
|
8.00 (5.24)
|
0.075
|
|
0.144
|
|
Mortality (%)
|
0 No
|
302.0 (67.4)
|
809.1 (69.9)
|
0.587
|
|
0.054
|
|
|
1 Yes
|
146.0 (32.6)
|
347.9 (30.1)
|
|
|
|
|
Followup (mean (SD))
|
|
51.02 (32.44)
|
51.30 (38.21)
|
0.933
|
|
0.008
|
|
Disease_free (%)
|
0 No
|
344.8 (77.0)
|
932.1 (80.6)
|
0.359
|
|
0.088
|
|
|
1 Yes
|
103.2 (23.0)
|
224.9 (19.4)
|
|
|
|
|
Followup_DF (mean (SD))
|
|
36.61 (24.99)
|
36.52 (29.49)
|
0.973
|
|
0.003
|
Before
before overlap weighting
|
|
level
|
1 Robot
|
2 LPS+LESS
|
p
|
test
|
SMD
|
|
n
|
|
448
|
1157
|
|
|
|
|
Clavien_Dindo_classification (%)
|
0 No Complication
|
284 (63.4)
|
741 (64.0)
|
0.677
|
|
0.130
|
|
|
1 Grade I
|
78 (17.4)
|
174 (15.0)
|
|
|
|
|
|
2 Grade II
|
72 (16.1)
|
187 (16.2)
|
|
|
|
|
|
3 Grade IIIa
|
4 ( 0.9)
|
11 ( 1.0)
|
|
|
|
|
|
4 Grade IIIb
|
4 ( 0.9)
|
21 ( 1.8)
|
|
|
|
|
|
5 Grade IVa
|
3 ( 0.7)
|
16 ( 1.4)
|
|
|
|
|
|
6 Grade IVb
|
0 ( 0.0)
|
1 ( 0.1)
|
|
|
|
|
|
7 Grade V
|
3 ( 0.7)
|
6 ( 0.5)
|
|
|
|
|
術後住院天數_day (mean (SD))
|
|
7.60 (4.16)
|
8.47 (5.74)
|
0.004
|
|
0.172
|
|
Mortality (%)
|
0 No
|
321 (71.7)
|
778 (67.2)
|
0.100
|
|
0.096
|
|
|
1 Yes
|
127 (28.3)
|
379 (32.8)
|
|
|
|
|
Followup (mean (SD))
|
|
43.89 (30.48)
|
51.35 (39.23)
|
<0.001
|
|
0.212
|
|
Disease_free (%)
|
0 No
|
341 (76.1)
|
938 (81.1)
|
0.032
|
|
0.121
|
|
|
1 Yes
|
107 (23.9)
|
219 (18.9)
|
|
|
|
|
Followup_DF (mean (SD))
|
|
31.41 (22.57)
|
37.20 (30.14)
|
<0.001
|
|
0.218
|
4 Modeling
- CD:Clavien_Dindo_classification
- MOR:Mortality
- DF:Disease_free
- LOS:術後住院天數_day
4.1 p-value

4.2 coefficients
CD

MOR

DF

LOS

5 Survival Curve
OS

DFS
